Log in

STO:GETI.B - Getinge Stock Price, Forecast & News

SEK 174.95
-0.20 (-0.11 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
SEK 172.60
Now: SEK 174.95
SEK 176.85
50-Day Range
SEK 164
MA: SEK 175.31
SEK 182.15
52-Week Range
SEK 99.88
Now: SEK 174.95
SEK 182.06
Volume754,557 shs
Average Volume1.32 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business area offers products and services geared toward the hospital and elderly care markets, including solutions for preventing the risk of pressure ulcers and deep vein thrombosis, and the Infection Control business area features systems for preventing the occurrence and spread of infection. Read More…

Industry, Sector and Symbol

Industry N/A
Current SymbolSTO:GETI.B



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive GETI.B News and Ratings via Email

Sign-up to receive the latest news and ratings for GETI.B and its competitors with MarketBeat's FREE daily newsletter.

Getinge (STO:GETI.B) Frequently Asked Questions

What is Getinge's stock symbol?

Getinge trades on the STO under the ticker symbol "GETI.B."

Has Getinge been receiving favorable news coverage?

News headlines about GETI.B stock have trended somewhat positive this week, InfoTrie reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Getinge earned a coverage optimism score of 0.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Getinge.

What other stocks do shareholders of Getinge own?

Who are Getinge's key executives?

Getinge's management team includes the folowing people:
  • Carl Bennet, Chairman of the Board (Age 67)
  • Mattias Perjos, President, Chief Executive Officer, Director (Age 46)
  • Johan Stern, Vice Chairman of the Board (Age 67)
  • Lars Sandstrom, Chief Financial Officer (Age 46)
  • Magnus Lundback, Executive Vice President, Human Resources & Sustainability (Age 49)
  • Lena Hagman, Executive Vice President, Quality Regulatory Compliance (Age 53)
  • Jeanette Heden Carlsson, Executive Vice President, Communications & Brand Management (Age 52)
  • Carsten Blecker, Chief Commercial Officer (Age 52)
  • Harald Castler, President, Life Science (Age 61)
  • Frederic Pette, Acting President Surgical Workflows (Age 45)

What is Getinge's stock price today?

One share of GETI.B stock can currently be purchased for approximately SEK 174.95.

What is Getinge's official website?

The official website for Getinge is http://www.getingegroup.com/.

How can I contact Getinge?

Getinge's mailing address is Lindholmspiren 7, GOTEBORG, 417 56, Sweden. The company can be reached via phone at +46-3-5155500.

MarketBeat Community Rating for Getinge (STO GETI.B)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  18
MarketBeat's community ratings are surveys of what our community members think about Getinge and other stocks. Vote "Outperform" if you believe GETI.B will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GETI.B will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel